7th Metabolic Continuum Roundtable Annual Meeting – Steatotic Liver Disease (MASLD/MASH): Disease Burden - Patient Reported Outcomes - Health Economics: Payor & Societal Perspectives
November 10, 2023, Boston, MA

Contact Us »

6th NASH Roundtable Forum – Clinical Trials with Non-Invasive Tests (NITs) Instead of Histology: Fact or Fancy?

More information »

5th NASH Roundtable Virtual Forum – Is Digital Pathology a Game-Changer for Histology for NASH Drug Development?

More information »


Fact Sheet: NASH Roundtable™, leading clinical development experts addressing challenges in NASH drug development

View Fact Sheet »


September 1, 2023

Nonalcoholic fatty liver disease (NAFLD) and associated mortality in individuals with type 2 diabetes, pre-diabetes, metabolically unhealthy, and metabolically healthy individuals in the United States Read More »

August 19, 2023

Progression of nonalcoholic fatty liver disease and long-term outcomes: A nationwide paired liver biopsy cohort study Read More »

August 7, 2023

Clinical care pathway to detect advanced liver disease in patients with type 2 diabetes through automated fibrosis score calculation and electronic reminder messages: a randomised controlled trial Read More »

August 3, 2023

Confirmatory biomarker diagnostic studies are not needed when transitioning from NAFLD to MASLD Read More »